AHA Comments to DEA on 2019 Controlled Substances Quotas

AHA comments on the Drug Enforcement Administration’s (DEA) notice of proposed rulemaking on aggregate production quotas for Schedule I and II controlled substances.

Related Resources

Letter/Comment
Public
The AHA urges the Department of Health and Human Services to take a number of regulatory actions that would help hospitals and health systems better…
Advisory
Member
At Issue: The Department of Homeland Security (DHS) on Feb. 24 began implementing new standards for immigration public charge decisions. When making certain…
Special Bulletin
Public
The Centers for Medicare & Medicaid Services (CMS) Feb. 20 issued a rule proposing changes to the Comprehensive Care for Joint Replacement (CJR) model,…
Special Bulletin
Public
President Trump today submitted to Congress his budget request for fiscal year (FY) 2021. The budget request, which is not binding, proposes hundreds of…
Special Bulletin
Public
Special Bulletin
Member
The Centers for Medicare & Medicaid Services (CMS) Jan. 31 issued a proposed rule that would implement the standards governing health insurance issuers and…